Research
Pancreatic cancer remains one of the leading causes of cancer-related deaths in the United States. There is a critical need for innovative approaches to enhance early diagnosis and treatment of the disease.
Ongoing studies at the Pancreatic Cancer Specialty Care Center include:
- investigational chemotherapy
- radiation therapy, including: CyberKnife, Trilogy, image-guided radiation therapy (IGRT), and
intensity-modulated radiation therapy (IMRT)
- vaccines for pancreatic cancer
- innovative chemoembolization
- use of new viruses to destroy tumors
- genetic research to improve early detection methods
View Clinical Trials available at UPMC Cancer Centers.